top of page

Optibrium Launches StarDrop 8, Bringing Real-Time Collaboration to Molecular Design

StarDrop 8 integrates real-time collaboration into compound design and optimisation, streamlining decision-making and improving team productivity.

Optibrium Launches StarDrop 8, Bringing Real-Time Collaboration to Molecular Design

Optibrium, a leading developer of software and AI solutions for molecular design, has announced the release of StarDrop 8, the most significant update to its comprehensive discovery platform in its 20-year history.


StarDrop 8 introduces real-time collaboration across every stage of the compound design and optimisation workflow, enabling teams to make better decisions together and progress faster from hit to candidate.


Unlike existing discovery collaboration software, StarDrop 8 delivers an all-in-one solution for medicinal chemists, embedding collaboration directly into a platform that combines interactive data visualisation, structure-activity relationship analyses, compound design, and a wide range of in silico modelling and generative chemistry capabilities.


According to Optibrium, the integration of real-time collaboration means discovery teams can now “leverage their collective knowledge at every step to prioritise the compounds most likely to succeed and focus synthesis efforts where they matter.”

A Connected Platform for Discovery Teams


StarDrop 8 aims to improve how discovery teams work together by:

  • Centralising all project information and analyses in a secure shared environment accessible to users working from any location or time zone.

  • Ensuring everyone works with the latest compounds and data, preventing time lost from duplicated efforts.

  • Allowing flexible, individual analysis while instantly sharing insights and results with colleagues.

  • Capturing designs and decisions throughout the discovery process to identify successful strategies for future work.


The latest release also strengthens StarDrop’s predictive capabilities, adding new and updated models for key ADME properties and additional molecular property calculators.


“Drug Discovery Is Not a Solo Venture”


“Drug discovery is not a solo venture,” said Edmund Champness, Chief Scientific Officer at Optibrium. “Our customers consistently tell us that to work effectively, chemists need to be sure they’re looking at exactly the same compounds and data as their colleagues. We’ve developed StarDrop 8 around this feedback, without compromising on StarDrop’s flexibility, which enables each user to analyse and visualise data in their own way.”


“Its real-time collaborative environment ensures that teams stay aligned on the latest project information, regardless of distances or time zones,” Champness added. “The result is increased productivity and improved decision-making that help address the critical challenges of time and cost in discovery.”

author profile picture

Author

BioFocus Newsroom

bottom of page